Maturitas
Volume 55, Issue 1 , Pages 27-35 , 20 August 2006

Vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Indian women

Received 22 June 2005 ,Revised 30 December 2005 ,Accepted 3 January 2006.

References 

  1. Turner RT, Riggs BL, Spelsberg TC. Skeletal effects of estrogen. Endocr Rev. 1994;15:275–300
  2. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, Deluca HF. Intestinal calcium absorption and serum Vitamin D metabolites in normal subjects and osteoporotic patients. J Clin Invest. 1979;64:729–736
  3. Gallagher JC, Riggs BL, Hamstra A, Deluca HF. The effect of estrogen therapy on calcium absorption and Vitamin D metabolism in postmenopausal osteoporosis. Clin Res. 1978;25:415A;Abstract
  4. Bunce CM, Brown G, Hewison M. Vitamin D and hematopoiesis. Trends Endocrinol Metab. 1997;8:245–251
  5. Ferrari S, Bonjour JP, Rizzoli R. The Vitamin D receptor gene and calcium metabolism. Trends Endocrinol Metab. 1997;9:259–264
  6. Walters MR. Newly identified actions of the Vitamin D endocrine system. Endocr Rev. 1992;13:719–764
  7. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci. 1992;89:6665–6669
  8. Peacock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S. Genetic determinants of bone mass in adults: a twin study. J Clin Invest. 1987;80:706–710
  9. Seeman E, Hopper JR, Bach LA, et al. Reduced bone mass in daughters of women with osteoporosis. N Engl J Med. 1989;320:554–558
  10. Stewart TL, Ralston SH. Role of genetic factors in pathogenesis of osteoporosis. J Endocrinol. 2000;166:235–245
  11. Rizzoli R, Bonjour JP, Ferrari SL. Osteoporosis, genetics and hormones. J Mol Endocrinol. 2001;26:79–94
  12. Kurabayashi T, Tomita M, Matsushita H, et al. Association Vitamin D and estrogen receptor gene polymorphism with effect of hormone replacement therapy on bone mineral density in Japanese women. Am J Obstet Gynecol. 1999;180:1115–1120
  13. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from Vitamin D receptor alleles. Nature. 1994;367:284–287
  14. Tornout JMV, Sain ZJ, Loro ML, Sayre J, Roe TF, Gilsanz V. Vitamin D receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med. 1997;10:77–82
  15. Gennari L, Becherini L, Masi L, et al. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab. 1998;83:933–944
  16. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour J-P. Vitamin D receptor polymorphisms and change in lumbar spine bone mineral density. Lancet. 1995;345:423–424
  17. Kikuchi R, Uemura T, Gorai I, Ohno S, Minaguchi H. Early and late postmenopausal bone loss is associated with BsmI Vitamin D receptor gene polymorphism in Japanese women. Calcif Tissue Int. 1999;64:102–106
  18. Graafmans WC, Lips P, Ooms ME, Van Leeuwen JPTM, Pols HAP, Uitterlinden AG. The effect of Vitamin D supplementation on the bone mineral density of the femoral neck is associated with Vitamin D receptor genotype. J Bone Miner Res. 1997;12:1241–1245
  19. Lim SK, Park YS, Park JM, et al. Lack of association between Vitamin D receptor genotypes and osteoporosis in Koreans. J Clin Endocrin Metab. 1995;80:3677–3681
  20. Looney JE, Yoon H, Fisher M, et al. Lack of high prevalence of the BB Vitamin D receptor genotype in severely osteoporotic women. J Clin Endocrin Metab. 1995;80:2158–2162
  21. Vandevyver C, Wylin T, Cassiman JJ, Raus J, Geusens P. Influence of the Vitamin D receptor gene alleles on bone mineral density in postmenopausal and osteoporotic women. J Bone Miner Res. 1997;12:241–247
  22. Gennari L, Merlotti D, De Paola V, et al. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGe review. Am J Epidemiol. 2005;161:307–320
  23. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037–2048
  24. Dvornyk V, Long JR, Xiong DH, et al. Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis. BMC Genet. 2004;5:4–18
  25. Ortiz O, Russell M, Daley TL, et al. Differences in skeletal muscle and bone mineral mass between black and white females and their relevance to estimates of body composition. Am J Clin Nutr. 1992;55:8–13
  26. Ioannidis JPA, Ntzani EE, Trikalinos TA. Racial differences in genetic effects for complex diseases. Nat Genet. 2004;36:1312–1318
  27. Mitra S, Desai M, Khatkhatay MI. Association of estrogen receptor α gene polymorphisms with bone mineral density in postmenopausal Indian women. Mol Genet Metab. 2006;87:80–87
  28. WHO: consensus development conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993; 94: 646–50.
  29. Lahiri DK, Nurberger JI. A rapid non-enzymatic method for preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res. 1991;19:5444
  30. Miyamoto KI, Kesterson RA, Yamamoto H, et al. Structural organization of human Vitamin D receptor chromosomal gene and its promoter. Mol Encrinol. 1997;11:1165–1179
  31. Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphism is associated with Grave's disease in the Japanese population. J Clin Endocrinol Metab. 2000;85:4639–4643
  32. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of polymorphism at translation initiation site of the Vitamin D receptor gene is associated with low bone mineral density in post menopausal Mexican–American women. J Bone Miner Res. 1997;12:915–921
  33. Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH. Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet. 1984;36:1239–1258
  34. Zhang YY, Long JR, Liu PY, Shen H, Zhao LJ, Deng HW. Estrogen receptor α and Vitamin D receptor gene polymorphism and bone mineral density: association study of healthy pre- and postmenopausal Chinese women. Biophy Biochem Res Commun. 2003;308:777–783
  35. Carling T, Akerstrom G, Rastad J, Westin G. Vitamin D receptor (VDR) and parathyroid mRNA levels corresponds to polymorphic VDR allele in human parathyroid tumors. J Clin Endocrinol Metab. 1998;83:2255–2259
  36. Ban Y, Taniyama M, Yanagawa T, et al. Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type I diabetes milletus in the Japanese population. BMC Med Genet. 2001;2:7–13
  37. Houston LA, Grant SFA, Reid DM, Ralston SH. Vitamin D receptor polymorphism, bone mineral density and osteoporotic vertebral fracture: studies in UK population. Bone. 1996;18:249–252
  38. Dawson-Hughes B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to Vitamin D receptor genotype. J Clin Endocrinol Metab. 1995;80:3657–3661
  39. Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in the human Vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000;14:401–420
  40. Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D. The Vitamin D receptor gene start codon polymorphism: a functional analysis of Fok I variants. J Bone Miner Res. 1998;13:1691–1699
  41. Zajickova K, Zofkova I, Banbouh R, Krepelova A. Vitamin D receptor gene polymorphisms, bone mineral density and bone turnover: FokI genotype is related to postmenopausal bone mass. Physiol Res. 2002;51:501–509
  42. Uitterlinden AG, Fang Y, Bergink AP, Van Meurs JB, Van Leeuwen HP, Pols HA. The role of Vitamin D receptor gene polymorphisms in bone biology. Mol Cell Endocrinol. 2002;197:15–21
  43. Katzburg S, Hendel D, Waisman A, Posner GH, Kaye AM, Somjen D. Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts. J Steroid Biochem Mol Biol. 2004;88:213–219
  44. Young RP, Lau EM, Birjandi Z, Critchley JA, Woo J. Interethnic differences in hip fracture rate and the Vitamin D receptor polymorphism. Lancet. 1996;348:688–689
  45. Zmuda JM, Cauley JA, Ferrelle RE. Vitamin D receptor gene variants and osteoporosis. Epidemiol Rev. 2000;22:203–217
  46. Willing M, Sowers M, Aron D, et al. Bone mineral density and its changes in white women: estrogen and Vitamin D receptor gene and their interaction. J. Bone Miner Res. 1998;13:695–705
  47. Thakkinstian A, D’Este C, Eisman J, Nguyen T, Attia J. Meta-analysis of molecular association studies: Vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res. 2004;19:419–428
  48. Ioannidis JPA, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet. 2003;361:567–571
  49. Pyo CW, Hur SS, Kim YK, et al. Polymorphisms of IL -1B, IL -1RN, IL -2, IL -4, IL -6, IL -10 and IFN- γ genes in the Korean population. Hum Immunol. 2003;64:979–989

PII: S0378-5122(06)00005-3

doi: 10.1016/j.maturitas.2006.01.003

Maturitas
Volume 55, Issue 1 , Pages 27-35 , 20 August 2006

Article Tools

* Image Usage & Resolution